NCT03758261

Brief Summary

Continuous paravertebral analgesia and erector spinae plane blockade (ESP) are accepted techniques at University of Pittsburgh Medical Center (UPMC) for the management of thoracic pain following surgery and trauma. Recently, an increasing number of erector spinae plane nerve blocks are being performed as it has been demonstrated in our institution, and via case reports that the blocks provide clinical effectiveness, but may have a better side-effect profile than the paravertebral nerve block. However, the relative efficacy of ESP compared to paravertebral nerve block remains to be established for video assisted thoracoscopic surgery (VATS). This is a prospective randomized study intended to assess the efficacy, safety and side-effect profile of continuous erector spinae plane analgesia versus continuous paravertebral analgesia for VATS procedures. It will include 60 patients presenting to UPMC Passavant for a VATS procedure. Patients will be randomized 1:1 to receive either a nerve block via continuous paravertebral infusion or via erector spinae plane infusion. In addition, to treat breakthrough pain, the patients in both arms will receive multimodal adjunctive therapy per routine. Bupivacaine and ropivacaine are FDA approved for use in nerve block catheters. The primary outcome will be to compare analgesic efficacy between the two nerve blocks as defined by total opioid consumption and pain scores on the numeric pain rating scale. Secondary outcomes include incentive spirometer amounts (baseline vs daily score postoperatively), length of stay, duration of catheter and report of adverse events or complications. Other data points include number of chest tubes and location and level of catheter and nerve block placement as well as number of blocks per case.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 29, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

March 11, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2020

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2020

Completed
3 years until next milestone

Results Posted

Study results publicly available

July 3, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

1.3 years

First QC Date

November 27, 2018

Results QC Date

April 28, 2023

Last Update Submit

June 13, 2023

Conditions

Keywords

VATSRegional AnesthesiaParavertebral nerve blockErector Spinae nerve blockVideo assisted thoracoscopic surgery

Outcome Measures

Primary Outcomes (2)

  • Total Opioid Consumption

    Morphine equivalents (total OME)

    1 day post catheter removal

  • Patient Reported Pain Scores

    Visual analog scale. Scale is from 0 to 10 numerical pain rating scale. 0 indicates no pain. 10 indicates maximum level of pain. Higher scores indicate worse pain level. Pain score will be a single number from 0 to 10.

    1 day post catheter removal

Secondary Outcomes (5)

  • Amount Achieved on Incentive Spirometer

    1 day post catheter removal

  • Length of Hospital Stay

    Up to 2 weeks on average

  • Time Catheter Remains Inserted in Body

    6 days

  • Averaged Total of Narcotic Usage

    0-120 hours post-operative

  • Report of Adverse Events From Catheter Placement

    1 day post catheter removal

Study Arms (2)

Erector Spinae Nerve Block

OTHER

Erector Spinae nerve block

Drug: Erector Spinae nerve block

Paravertebral Nerve Block

OTHER

Paravertebral nerve block

Drug: Paravertebral nerve block

Interventions

The patient will be placed in a sitting position and the level of needle insertion will be marked corresponding to the level of surgical incision. With sterile technique an ultrasound Paravertebral Nerve Block will be performed.

Paravertebral Nerve Block

The patient will be placed in a sitting position and the level of needle insertion will be marked corresponding to the level of surgical incision. With sterile technique an ultrasound erector spinae nerve block will be performed.

Erector Spinae Nerve Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing VATS agreeable to have a nerve block as analgesic technique
  • Age: 18 years old and older.
  • ASA (American Society of Anesthesiologists Class) I-IV

You may not qualify if:

  • Cognitive impairment that would not allow effective nerve block placement or gathering information related to the study (ex. pain score).
  • Contraindications for nerve block placement such as coagulopathy, use of clopidogrel in the past 48hs, patients on dual antiplatelet therapy, infection at the site of puncture, patient refusal, allergy to local anesthetics.
  • Chronic opiate consumption
  • Patient expected to be on therapeutic anticoagulation post procedure.
  • Pregnancy
  • Comorbid conditions: Any comorbid condition that in the judgment of the anesthesiologist would preclude the patient from any aspect of the study (ex. sepsis, possibly abnormalities of the thoracic spine or paravertebral anatomy such as neoplastic mass occupying the space, empyema, increased intracranial pressure)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Passavant

Pittsburgh, Pennsylvania, 15237, United States

Location

Related Publications (6)

  • D'Ercole F, Arora H, Kumar PA. Paravertebral Block for Thoracic Surgery. J Cardiothorac Vasc Anesth. 2018 Apr;32(2):915-927. doi: 10.1053/j.jvca.2017.10.003. Epub 2017 Oct 4.

    PMID: 29169795BACKGROUND
  • Yeung JH, Gates S, Naidu BV, Wilson MJ, Gao Smith F. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev. 2016 Feb 21;2(2):CD009121. doi: 10.1002/14651858.CD009121.pub2.

    PMID: 26897642BACKGROUND
  • Tsui BCH, Fonseca A, Munshey F, McFadyen G, Caruso TJ. The erector spinae plane (ESP) block: A pooled review of 242 cases. J Clin Anesth. 2019 Mar;53:29-34. doi: 10.1016/j.jclinane.2018.09.036. Epub 2018 Oct 3.

    PMID: 30292068BACKGROUND
  • Hamilton DL, Manickam B. Erector spinae plane block for pain relief in rib fractures. Br J Anaesth. 2017 Mar 1;118(3):474-475. doi: 10.1093/bja/aex013. No abstract available.

    PMID: 28203765BACKGROUND
  • Ueshima H, Otake H. RETRACTED: Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery. J Clin Anesth. 2017 May;38:137. doi: 10.1016/j.jclinane.2016.12.028. Epub 2017 Feb 17. No abstract available.

    PMID: 28372654BACKGROUND
  • Luis-Navarro JC, Seda-Guzman M, Luis-Moreno C, Lopez-Romero JL. The erector spinae plane block in 4 cases of video-assisted thoracic surgery. Rev Esp Anestesiol Reanim (Engl Ed). 2018 Apr;65(4):204-208. doi: 10.1016/j.redar.2017.12.004. Epub 2018 Jan 11. English, Spanish.

    PMID: 29336785BACKGROUND

Results Point of Contact

Title
Dr. Charles Luke
Organization
University of Pittsburgh Medical Center

Study Officials

  • Charles Luke, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 groups of patients will be studied simultaneously. One group will have the intervention of the nerve block in the erector spinae approach and the other group will have the nerve block in the traditional paravertebral approach.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

November 27, 2018

First Posted

November 29, 2018

Study Start

March 11, 2019

Primary Completion

June 12, 2020

Study Completion

June 25, 2020

Last Updated

July 3, 2023

Results First Posted

July 3, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations